Stockscreener 앱 받기
4.365
4.93%
0.205
전일 마감가:
$4.16
열려 있는:
$4.17
하루 거래량:
495.78K
Relative Volume:
0.57
시가총액:
$331.16M
수익:
$73.48M
순이익/손실:
$-108.30M
주가수익비율:
-1.94
EPS:
-2.25
순현금흐름:
$-67.17M
1주 성능:
+16.40%
1개월 성능:
+40.35%
6개월 성능:
-22.61%
1년 성능:
+183.44%
1일 변동 폭
$4.0101
$4.49
1주일 범위
$3.62
$4.49
52주 변동 폭
$1.135
$7.20
Personalis Inc Stock (PSNL) Company Profile
명칭
Personalis Inc
전화
650-752-1300
주소
6600 DUMBARTON CIRCLE, FREMONT, CA
PSNL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
4.37 | 331.16M | 73.48M | -108.30M | -67.17M | -2.25 |
|
TMO
Thermo Fisher Scientific Inc
|
423.52 | 159.05B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
199.05 | 140.21B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
478.45 | 35.17B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
109.13 | 30.47B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
153.81 | 26.47B | 15.41B | 1.37B | 2.11B | 7.50 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-17 | 개시 | Craig Hallum | Buy |
| 2023-02-06 | 업그레이드 | Needham | Hold → Buy |
| 2022-01-07 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-11-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | 다운그레이드 | Needham | Buy → Hold |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-09-20 | 재확인 | Needham | Buy |
| 2021-05-06 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-01-28 | 개시 | Truist | Buy |
| 2021-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-12 | 재확인 | Needham | Buy |
| 2020-11-06 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-10-19 | 개시 | Citigroup | Buy |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-08-27 | 개시 | H.C. Wainwright | Buy |
| 2020-08-18 | 개시 | Needham | Buy |
| 2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | 개시 | BofA/Merrill | Neutral |
| 2019-07-15 | 개시 | Cowen | Outperform |
| 2019-07-15 | 개시 | Morgan Stanley | Overweight |
| 2019-07-15 | 개시 | Oppenheimer | Outperform |
모두보기
Personalis Inc 주식(PSNL)의 최신 뉴스
Personalis Inc (PSNL) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Personalis Inc (PSNL) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Market Momentum Report: Personalis Inc (PSNL)’s Negative Close at 3.78 - DWinneX
Results from Personalis Inc (PSNL) show potential - uspostnews.com
Examining the Potential Price Growth of Personalis Inc (PSNL) - knoxdaily.com
Personalis (PSNL) Reveals Promising Interim Results in Colorecta - GuruFocus
Personalis’ NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study - BioSpace
Personalis' NeXT Personal® Detects 100% of Colorectal Cancer Rel - GuruFocus
Investor’s Delight: Personalis Inc (PSNL) Closes Weak at 4.14, Down -1.90 - DWinneX
Gaining Ground: Personalis Inc (PSNL) Closes Lower at 3.51, Down -3.04 - DWinneX
PSNL Stock Sees Surge of Approximately 12.88% in Last Five Days - knoxdaily.com
Several Personalis Insiders Sell Shares Sending Potential Negative Signal - simplywall.st
Personalis Inc (PSNL) produces promising results - uspostnews.com
Personalis to Announce First Quarter 2025 Financial Results - BioSpace
Is Personalis, Inc. (PSNL) the Best Multibagger Penny Stock to Buy According to Billionaires? - Insider Monkey
10 Best Multibagger Penny Stocks to Buy According to Billionaires - Insider Monkey
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection | PSNL Stock News - GuruFocus
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection - Business Wire
LPL Financial LLC Sells 6,773 Shares of Personalis, Inc. (NASDAQ:PSNL) - Defense World
Renaissance Technologies LLC Trims Stock Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World
PSNL Stock Sees Decline of Approximately -2.66% in Last Five Days - knoxdaily.com
Arrowstreet Capital Limited Partnership Lowers Stock Holdings in Personalis, Inc. (NASDAQ:PSNL) - Defense World
Raymond James Financial Inc. Buys New Stake in Personalis, Inc. (NASDAQ:PSNL) - Defense World
American Century Companies Inc. Buys 25,011 Shares of Personalis, Inc. (NASDAQ:PSNL) - Defense World
Needham & Company LLC Reiterates “Buy” Rating for Personalis (NASDAQ:PSNL) - Defense World
With 33% stake, Personalis, Inc. (NASDAQ:PSNL) seems to have captured institutional investors' interest - Yahoo Finance
What 5 Analyst Ratings Have To Say About Personalis - Benzinga
Personalis to Participate at the 24th Annual Needham Virtual Healthcare Conference - BioSpace
Personalis, Inc. (NASDAQ:PSNL) Shares Sold by Connor Clark & Lunn Investment Management Ltd. - Defense World
Personalis Inc’s (PSNL) Stock Is Harder To Predict Than You Think - Stocks Register
What You Can Learn From Personalis, Inc.'s (NASDAQ:PSNL) P/S After Its 40% Share Price Crash - simplywall.st
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Personalis (NASDAQ:PSNL) Now Covered by Craig Hallum - Defense World
Craig-Hallum Initiates Coverage of Personalis (PSNL) with Buy Recommendation - Nasdaq
This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Craig Hallum Initiates Coverage on Personalis With Buy Rating, $8 Price Target -March 17, 2025 at 07:58 am EDT - Marketscreener.com
Hold Rating for Personalis: Balancing Strong Enterprise Sales and Future Uncertainties - TipRanks
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip - Benzinga
Personalis Stock Price, Quotes and Forecasts | NASDAQ:PSNL - Benzinga
Personalis stock target cut to $7 by BTIG, maintains Buy rating - Investing.com Canada
New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection - Yahoo Finance
Can This New Blood Test Revolutionize Breast Cancer Monitoring? Detects Recurrence Years Before Imaging - Stock Titan
Personalis’ (PSNL) “Buy” Rating Reiterated at HC Wainwright - Defense World
Needham & Company LLC Cuts Personalis (NASDAQ:PSNL) Price Target to $7.00 - Defense World
Personalis, Inc. (NASDAQ:PSNL) Just Reported Earnings, And Analysts Cut Their Target Price - Simply Wall St
Personalis (NASDAQ:PSNL) Price Target Lowered to $7.00 at Needham & Company LLC - MarketBeat
Personalis Full Year 2024 Earnings: Beats Expectations - Yahoo
Personalis (NASDAQ:PSNL) Announces Quarterly Earnings Results - MarketBeat
Personalis stock target cut to $7.00 at Needham, retains buy rating By Investing.com - Investing.com South Africa
Personalis (NASDAQ:PSNL) Announces Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat
Personalis Inc (PSNL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Personalis Inc 주식 (PSNL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jan 28 '25 |
Sale |
5.79 |
519 |
3,005 |
123,367 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Dec 16 '24 |
Sale |
3.82 |
4,834 |
18,466 |
123,886 |
| Moore Stephen Michael | SVP and Chief Legal Officer |
Dec 16 '24 |
Sale |
3.82 |
1,513 |
5,780 |
65,875 |
| Tachibana Aaron | CFO AND COO |
Dec 16 '24 |
Sale |
3.82 |
6,865 |
26,224 |
167,098 |
| Tachibana Aaron | CFO AND COO |
Nov 18 '24 |
Sale |
3.79 |
1,307 |
4,954 |
173,963 |
| Moore Stephen Michael | SVP and Chief Legal Officer |
Nov 18 '24 |
Sale |
3.79 |
1,693 |
6,416 |
67,388 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Nov 18 '24 |
Sale |
3.79 |
921 |
3,491 |
128,720 |
| Hall Christopher M | PRESIDENT AND CEO |
Nov 01 '24 |
Sale |
5.38 |
26,443 |
142,263 |
178,098 |
| Tempus AI, Inc. | 10% Owner |
Aug 16 '24 |
Buy |
5.07 |
3,500,000 |
17,745,000 |
12,718,800 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jul 30 '24 |
Sale |
2.97 |
524 |
1,556 |
127,227 |
0.15%
자본화:
|
볼륨(24시간):